Literature DB >> 32768421

CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos.

Gopal Kushawah1, Luis Hernandez-Huertas2, Joaquin Abugattas-Nuñez Del Prado3, Juan R Martinez-Morales4, Michelle L DeVore1, Huzaifa Hassan1, Ismael Moreno-Sanchez2, Laura Tomas-Gallardo5, Alejandro Diaz-Moscoso5, Dahiana E Monges2, Javier R Guelfo2, William C Theune6, Emry O Brannan6, Wei Wang1, Timothy J Corbin1, Andrea M Moran1, Alejandro Sánchez Alvarado7, Edward Málaga-Trillo8, Carter M Takacs6, Ariel A Bazzini9, Miguel A Moreno-Mateos10.   

Abstract

Early embryonic development is driven exclusively by maternal gene products deposited into the oocyte. Although critical in establishing early developmental programs, maternal gene functions have remained elusive due to a paucity of techniques for their systematic disruption and assessment. CRISPR-Cas13 systems have recently been employed to degrade RNA in yeast, plants, and mammalian cell lines. However, no systematic study of the potential of Cas13 has been carried out in an animal system. Here, we show that CRISPR-RfxCas13d (CasRx) is an effective and precise system to deplete specific mRNA transcripts in zebrafish embryos. We demonstrate that zygotically expressed and maternally provided transcripts are efficiently targeted, resulting in a 76% average decrease in transcript levels and recapitulation of well-known embryonic phenotypes. Moreover, we show that this system can be used in medaka, killifish, and mouse embryos. Altogether, our results demonstrate that CRISPR-RfxCas13d is an efficient knockdown platform to interrogate gene function in animal embryos.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas13; Cas13d; MZT; RNA targeting; early development; embryogenesis; killifish; knockdown; medaka; zebrafish

Mesh:

Substances:

Year:  2020        PMID: 32768421     DOI: 10.1016/j.devcel.2020.07.013

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  36 in total

1.  CRISPR gets crunchy.

Authors:  Jim Kling
Journal:  Lab Anim (NY)       Date:  2021-01       Impact factor: 12.625

2.  Determining the Role of Maternally-Expressed Genes in Early Development with Maternal Crispants.

Authors:  Cara E Moravec; Gabriella C Voit; Francisco Pelegri
Journal:  J Vis Exp       Date:  2021-12-21       Impact factor: 1.355

3.  Analyzing the Role of Heparan Sulfate Proteoglycans in Axon Guidance In Vivo in Zebrafish.

Authors:  Fabienne E Poulain
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Screening circular RNAs with functional potential using the RfxCas13d/BSJ-gRNA system.

Authors:  Siqi Li; Hao Wu; Ling-Ling Chen
Journal:  Nat Protoc       Date:  2022-07-13       Impact factor: 17.021

5.  High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Authors:  Huawei Tong; Jia Huang; Qingquan Xiao; Bingbing He; Xue Dong; Yuanhua Liu; Xiali Yang; Dingyi Han; Zikang Wang; Xuchen Wang; Wenqin Ying; Runze Zhang; Yu Wei; Chunlong Xu; Yingsi Zhou; Yanfei Li; Minqing Cai; Qifang Wang; Mingxing Xue; Guoling Li; Kailun Fang; Hainan Zhang; Hui Yang
Journal:  Nat Biotechnol       Date:  2022-08-11       Impact factor: 68.164

Review 6.  ArcRNAs and the formation of nuclear bodies.

Authors:  Shinichi Nakagawa; Tomohiro Yamazaki; Taro Mannen; Tetsuro Hirose
Journal:  Mamm Genome       Date:  2021-06-03       Impact factor: 2.957

7.  Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes.

Authors:  Chunlong Xu; Yingsi Zhou; Qingquan Xiao; Bingbing He; Guannan Geng; Zikang Wang; Birong Cao; Xue Dong; Weiya Bai; Yifan Wang; Xiang Wang; Dongming Zhou; Tanglong Yuan; Xiaona Huo; Jinsheng Lai; Hui Yang
Journal:  Nat Methods       Date:  2021-05-03       Impact factor: 28.547

8.  Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells.

Authors:  Alejandro Méndez-Mancilla; Hans-Hermann Wessels; Mateusz Legut; Anastasia Kadina; Megumu Mabuchi; John Walker; G Brett Robb; Kevin Holden; Neville E Sanjana
Journal:  Cell Chem Biol       Date:  2021-08-02       Impact factor: 8.116

9.  Methods for in vitro CRISPR/CasRx-Mediated RNA Editing.

Authors:  Yu-Fan Chuang; Peng-Yuan Wang; Satheesh Kumar; Suraj Lama; Fan-Li Lin; Guei-Sheung Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-11

Review 10.  Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.

Authors:  Vanja Perčulija; Jinying Lin; Bo Zhang; Songying Ouyang
Journal:  Adv Sci (Weinh)       Date:  2021-05-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.